SMART-AML | SMART-AML: Shaping Marrow Adiposity to Redefine Treatment in Acute Myeloid Leukemia

Summary
Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy characterized by the uncontrolled proliferation of myeloid cells, which hijack the bone marrow (BM) and compromise its physiological functions. AML prognosis remains poor, with
Resources
Show all and search (0)
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101153517
Start date: 01-01-2025
End date: 31-12-2026
Total budget - Public funding: - 187 624,00 Euro
Cordis data

Original description

Acute Myeloid Leukemia (AML) is an aggressive hematologic malignancy characterized by the uncontrolled proliferation of myeloid cells, which hijack the bone marrow (BM) and compromise its physiological functions. AML prognosis remains poor, with

Status

SIGNED

Call topic

HORIZON-MSCA-2023-PF-01-01

Update Date

27-10-2025
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Horizon Europe
HORIZON.1 Excellent Science
HORIZON.1.2 Marie Skłodowska-Curie Actions (MSCA)
HORIZON.1.2.0 Cross-cutting call topics
HORIZON-MSCA-2023-PF-01
HORIZON-MSCA-2023-PF-01-01 MSCA Postdoctoral Fellowships 2023
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Organisations
Show all (1)
Powered by Chris Decubber BV